Dear chrisnial-ga;
Thank you for allowing me an opportunity to answer your interesting
question. Below you will find quite a number of trials as I described
in my clarification request:
New and Recruiting Trials
Preventive HIV Vaccine Trials (For HIV-negative individuals)
. . . . . . . .
A Study to Prepare for Future HIV Vaccine Studies
This study is currently recruiting patients.
Verified by National Institute of Allergy and Infectious Diseases (NIAID) June 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00029744
http://clinicaltrials.gov/ct/show/NCT00029744;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=1
. . . . . . . .
Screening Protocol for HIV Vaccine Studies
This study is currently recruiting patients.
Verified by National Institutes of Health Clinical Center (CC) February 11, 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00031304
http://clinicaltrials.gov/ct/show/NCT00031304;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=2
. . . . . . . .
Development of a New HIV Vaccine
This study is currently recruiting patients.
Verified by National Institute of Allergy and Infectious Diseases
(NIAID) March 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00051922
http://clinicaltrials.gov/ct/show/NCT00051922;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=3
. . . . . . . .
Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers
This study is not yet open for patient recruitment.
Verified by National Institute of Allergy and Infectious Diseases
(NIAID) November 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00062530
http://clinicaltrials.gov/ct/show/NCT00062530;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=4
. . . . . . . .
Safety of and Immune Response to Two HIV Vaccine Formulations
(rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected
Adults
This study is currently recruiting patients.
Verified by National Institute of Allergy and Infectious Diseases (NIAID) June 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00083603
http://clinicaltrials.gov/ct/show/NCT00083603;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=5
. . . . . . . .
Investigational HIV Vaccine Proof-of-Concept Study
This study is currently recruiting patients.
Verified by Merck December 2005
Sponsored by: Merck
Information provided by: Merck
ClinicalTrials.gov Identifier: NCT00095576
http://clinicaltrials.gov/ct/show/NCT00095576;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=6
. . . . . . . .
Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101)
in HIV Uninfected Adults
This study is currently recruiting patients.
Verified by National Institute of Allergy and Infectious Diseases (NIAID) May 2005
Sponsors and Collaborators: Alphavax
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00097838
http://clinicaltrials.gov/ct/show/NCT00097838;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=7
. . . . . . . .
Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521)
in Infants Born to HIV Infected Mothers
This study is not yet open for patient recruitment.
Verified by National Institute of Allergy and Infectious Diseases
(NIAID) April 2005
Sponsors and Collaborators: National Institute of Allergy and
Infectious Diseases (NIAID)
National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00098163
http://clinicaltrials.gov/ct/show/NCT00098163;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=8
. . . . . . . .
Study of HIV Preventive Vaccines Given With or Without an Adjuvant in
HIV Uninfected Adults
This study is not yet open for patient recruitment.
Verified by National Institute of Allergy and Infectious Diseases (NIAID) May 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00111605
http://clinicaltrials.gov/ct/show/NCT00111605;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=9
. . . . . . . .
Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag
DNA Alone or With IL-15 DNA) Given With or Without 3 Different Booster
Vaccinations in HIV Uninfected Adults
This study is currently recruiting patients.
Verified by National Institute of Allergy and Infectious Diseases
(NIAID) November 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00115960
http://clinicaltrials.gov/ct/show/NCT00115960;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=10
. . . . . . . .
Safety of and Immune Response to an Experimental HIV Vaccine
(VRC-HIVADV014-00-VP) in HIV Uninfected Adults
This study is not yet open for patient recruitment.
Verified by National Institute of Allergy and Infectious Diseases (NIAID) July 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00119873
http://clinicaltrials.gov/ct/show/NCT00119873;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=11
. . . . . . . .
Safety of and Immune Response to an HIV-1 Vaccine
(VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in
HIV Uninfected East African Adults
This study is not yet open for patient recruitment.
Verified by National Institute of Allergy and Infectious Diseases (NIAID) July 2005
Sponsors and Collaborators: National Institute of Allergy and
Infectious Diseases (NIAID)
Department of Defense
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00123968
http://clinicaltrials.gov/ct/show/NCT00123968;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=12
. . . . . . . .
Safety of and Immune Response to an Adenoviral HIV Vaccine
(VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine
(VRC-HIVDNA016-00-VP) in HIV Uninfected Adults
This study is not yet open for patient recruitment.
Verified by National Institute of Allergy and Infectious Diseases (NIAID) July 2005
Sponsors and Collaborators: International AIDS Vaccine Initiative
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00124007
http://clinicaltrials.gov/ct/show/NCT00124007;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=13
. . . . . . . .
Safety of and Immune Response to a DNA HIV Vaccine Followed By an
Adenoviral Vector HIV Vaccine in Healthy Adults
This study is not yet open for patient recruitment.
Verified by National Institute of Allergy and Infectious Diseases
(NIAID) November 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00125970
http://clinicaltrials.gov/ct/show/NCT00125970;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=14
. . . . . . . .
Safety of and Immune Response to Two Experimental Preventive HIV
Vaccines (EP HIV-1090 and EP-1043) Given Alone or in Combination in
Healthy, HIV-1 Uninfected Adults
This study is not yet open for patient recruitment.
Verified by National Institute of Allergy and Infectious Diseases
(NIAID) November 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00141024
http://clinicaltrials.gov/ct/show/NCT00141024;jsessionid=CAB2ADDCF9565E6F35CCE116FF7FCDE5?order=15
. . . . . . . .
New and Recruiting Trials
Therapeutic AIDS Vaccine Trials (For HIV-positive individuals)
. . . . . . . .
Safety/Immunogenicity of Immunizations of ALVAC-DC-SC Vs ALVAC-SC
This study is currently recruiting patients.
Verified by National Institute of Allergy and Infectious Diseases
(NIAID) March 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00026624
http://clinicaltrials.gov/ct/show/NCT00026624?order=1
. . . . . . . .
Effectiveness of and Immune Response to HIV Vaccination Followed by
Treatment Interruption in HIV Infected Patients
This study is currently recruiting patients.
Verified by National Institute of Allergy and Infectious Diseases
(NIAID) October 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00080106
http://clinicaltrials.gov/ct/show/NCT00080106?order=2
. . . . . . . .
Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy
This study is currently recruiting patients.
Verified by National Institute of Allergy and Infectious Diseases
(NIAID) November 2005
Sponsors and Collaborators: National Institute of Allergy and
Infectious Diseases (NIAID)
National Institute of Child Health and Human Development (NICHD)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00107549
http://clinicaltrials.gov/ct/show/NCT00107549?order=3
. . . . . . . .
Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With
Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy
(HAART)
This study is currently recruiting patients.
Verified by Marcus Altfeld, M.D., Ph.D. June 2005
Sponsors and Collaborators: Marcus Altfeld, M.D., Ph.D.
GlaxoSmithKline
Information provided by: Marcus Altfeld, M.D., Ph.D.
ClinicalTrials.gov Identifier: NCT00117429
http://clinicaltrials.gov/ct/show/NCT00117429?order=4
. . . . . . . .
Safety of and Immune Response to a DNA HIV Vaccine
(VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV
Infection
This study is currently recruiting patients.
Verified by National Institute of Allergy and Infectious Diseases (NIAID) July 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00125099
http://clinicaltrials.gov/ct/show/NCT00125099?order=5
. . . . . . . .
Immune Response to a Therapeutic HIV Vaccine Followed by Treatment
Interruption in Patients With Acute or Recent HIV Infection
This study is currently recruiting patients.
Verified by National Institute of Allergy and Infectious Diseases
(NIAID) December 2005
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious
Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00183261
http://clinicaltrials.gov/ct/show/NCT00183261?order=6
. . . . . . . .
77 Closed Trials
Preventive HIV Vaccine Trials (For HIV-negative individuals)
http://clinicaltrials.gov/search/term="HIV+Preventive+Vaccine"+[CONDITION]+AND+(No+longer+Recruiting+OR+Completed+OR+Terminated)+[OVERALL-STATUS]
33 Closed Trials
Therapeutic AIDS Vaccine Trials (For HIV-positive individuals)
http://clinicaltrials.gov/search/term="HIV+Therapeutic+Vaccine"+[CONDITION]+AND+(No+longer+Recruiting+OR+Completed+OR+Terminated)[OVERALL-STATUS]
I hope you find that my research exceeds your expectations. If you
have any questions about my research please post a clarification
request prior to rating the answer. Otherwise, I welcome your rating
and your final comments and I look forward to working with you again
in the near future. Thank you for bringing your question to us.
Best regards;
Tutuzdad ? Google Answers Researcher
OTHER INFORMATION SOURCES
AIDSINFO.COM
A Service of the US Department of Health and Human Services
http://www.actis.org/
CLINICAL TRIALS.GOV
http://clinicaltrials.gov/
SEARCH STRATEGY
SEARCH ENGINES USED:
Google ://www.google.com
SEARCH TERMS USED:
AIDS
VACCINE
TRIALS
STUDIES |